[Corrigendum] HsacircRNAG004213 promotes cisplatin sensitivity by regulating miR513b5p/PRPF39 in liver cancer.
Mol Med Rep
; 24(4)2021 10.
Article
en En
| MEDLINE
| ID: mdl-34396429
Following the publication of the above article, the authors have realized that, on p. 8, some of the supplementary data were cited incorrectly in the main text. In the right-hand column, second paragraph, the sentence beginning on line 5 should have read as follows (changed text is highlighted in bold): "Meanwhile, the expression of miR513b5p in tumor tissues was decreased and the expression of PRPF39 was increased in tumor tissues with knockout of circG004213 (Fig. S3D and E)." (i.e., the reference to Fig. S3C and D was incorrect.). The authors regret their oversight in failing to correct the inaccurate citation of the data in the paper, are grateful to the Editor for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 23: Article no. 421, 2021; DOI: 10.3892/mmr.2018.12060].
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
Idioma:
En
Revista:
Mol Med Rep
Año:
2021
Tipo del documento:
Article